J B Orthopaedics Ltd 12357341 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is the provision of specialist medical services Digita Accounts Production Advanced 6.30.9574.0 true 12357341 2024-01-01 2024-12-31 12357341 2024-12-31 12357341 bus:OrdinaryShareClass1 2024-12-31 12357341 core:CurrentFinancialInstruments 2024-12-31 12357341 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 12357341 core:MotorVehicles 2024-12-31 12357341 bus:SmallEntities 2024-01-01 2024-12-31 12357341 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 12357341 bus:FilletedAccounts 2024-01-01 2024-12-31 12357341 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12357341 bus:Director2 2024-01-01 2024-12-31 12357341 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 12357341 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12357341 core:MotorCars 2024-01-01 2024-12-31 12357341 core:MotorVehicles 2024-01-01 2024-12-31 12357341 countries:EnglandWales 2024-01-01 2024-12-31 12357341 2023-12-31 12357341 core:MotorVehicles 2023-12-31 12357341 2023-01-01 2023-12-31 12357341 2023-12-31 12357341 bus:OrdinaryShareClass1 2023-12-31 12357341 core:CurrentFinancialInstruments 2023-12-31 12357341 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 12357341 core:MotorVehicles 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12357341

J B Orthopaedics Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

J B Orthopaedics Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 6

 

J B Orthopaedics Ltd

(Registration number: 12357341)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

3

153,256

74,194

Current assets

 

Debtors

4

54,236

46,148

Cash at bank and in hand

 

286,791

313,713

 

341,027

359,861

Creditors: Amounts falling due within one year

5

(97,370)

(97,953)

Net current assets

 

243,657

261,908

Net assets

 

396,913

336,102

Capital and reserves

 

Called up share capital

6

10

10

Retained earnings

396,903

336,092

Shareholders' funds

 

396,913

336,102

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 23 September 2025 and signed on its behalf by:
 

.........................................
Mr James Berstock
Director

 

J B Orthopaedics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicles

20% reducing balance basis

 

J B Orthopaedics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

J B Orthopaedics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

 

J B Orthopaedics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

3

Tangible assets

Motor vehicles
 £

Total
£

Cost or valuation

At 1 January 2024

117,894

117,894

Additions

98,843

98,843

At 31 December 2024

216,737

216,737

Depreciation

At 1 January 2024

43,700

43,700

Charge for the year

19,781

19,781

At 31 December 2024

63,481

63,481

Carrying amount

At 31 December 2024

153,256

153,256

At 31 December 2023

74,194

74,194

4

Debtors

Current

2024
£

2023
£

Trade debtors

54,236

46,148

 

54,236

46,148

5

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

3,045

1,961

Taxation and social security

 

67,307

93,022

Accruals and deferred income

 

27,018

2,970

 

97,370

97,953

 

J B Orthopaedics Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

10

10

10

10